Sartorius Stedim Biotech SA (SRTOY)
23.29
-0.99
(-4.08%)
USD |
OTCM |
Oct 08, 16:00
Sartorius Stedim Biotech Enterprise Value : 25.18B for Oct. 8, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 08, 2026 | 25.18B |
| October 07, 2026 | 26.15B |
| October 06, 2026 | 26.35B |
| October 05, 2026 | 25.88B |
| October 02, 2026 | 25.39B |
| October 01, 2026 | 25.61B |
| September 30, 2026 | 27.33B |
| September 29, 2026 | 26.80B |
| September 28, 2026 | 26.77B |
| September 25, 2026 | 26.09B |
| September 24, 2026 | 26.41B |
| September 23, 2026 | 25.34B |
| September 22, 2026 | 25.46B |
| September 21, 2026 | 24.98B |
| September 18, 2026 | 24.51B |
| September 17, 2026 | 24.30B |
| September 16, 2026 | 23.93B |
| September 15, 2026 | 23.90B |
| September 14, 2026 | 23.41B |
| September 11, 2026 | 23.53B |
| September 10, 2026 | 23.46B |
| September 09, 2026 | 24.40B |
| September 08, 2026 | 23.91B |
| September 04, 2026 | 23.91B |
| September 03, 2026 | 24.91B |
| Date | Value |
|---|---|
| September 02, 2026 | 24.72B |
| September 01, 2026 | 24.53B |
| August 31, 2026 | 24.77B |
| August 28, 2026 | 25.14B |
| August 27, 2026 | 24.83B |
| August 26, 2026 | 24.28B |
| August 25, 2026 | 24.66B |
| August 24, 2026 | 24.32B |
| August 21, 2026 | 24.55B |
| August 20, 2026 | 24.79B |
| August 19, 2026 | 23.26B |
| August 18, 2026 | 22.71B |
| August 17, 2026 | 22.38B |
| August 14, 2026 | 22.63B |
| August 13, 2026 | 22.97B |
| August 12, 2026 | 22.64B |
| August 11, 2026 | 22.58B |
| August 10, 2026 | 22.87B |
| August 07, 2026 | 22.36B |
| August 06, 2026 | 21.70B |
| August 05, 2026 | 21.76B |
| August 04, 2026 | 21.84B |
| August 03, 2026 | 21.01B |
| July 31, 2026 | 21.17B |
| July 30, 2026 | 21.41B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Lifecore Biomedical, Inc. | 431.71M |
| Sanofi | 106.91B |
| Codexis, Inc. | 141.53M |
| Nicox SA | -- |
| Evotec SE | 569.38M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 108.95M |
| Revenue (Quarterly) | 890.29M |
| Total Expenses (Quarterly) | 782.15M |
| EPS Diluted (Quarterly) | 0.1111 |
| Gross Profit Margin (Quarterly) | 46.86% |
| Profit Margin (Quarterly) | 12.24% |
| Earnings Yield | 1.51% |
| Operating Earnings Yield | 2.87% |
| Normalized Earnings Yield | 1.758 |